Details

Re-evaluation decision RVD2023-17, 1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin and hydroxymethyl-5,5-dimethylhydantoin and its associated end-use products - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Apr 18, 2025 · edition #1
Timestamp
2025-04-18T21:04:17.683Z
Language
en
ID
160843
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview